Target intelligence / Profile preview

Enterovirus 71 capsid protein VP2 and VP3 antigenic regions (EV71 VP2/VP3 epitopes)

Target
EV71 VP2/VP3 epitopes
Molecular classification
Viral capsid protein, Antigenic determinant
01

Overview

Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD), which can lead to severe neurological complications such as brainstem encephalitis and pulmonary edema (Plevka et al., Science 2012). The viral capsid is an icosahedral structure composed of 60 protomers, each containing the structural proteins VP1, VP2, VP3, and VP4. The VP2 puff (EF loop) and VP3 knob (BC loop) are prominent surface-exposed regions that serve as critical antigenic determinants for the virus (Wang et al., Nat Struct Mol Biol 2012). These regions are essential for viral fitness as they are involved in the interaction with host cell receptors, including SCARB2 and PSGL-1, and facilitate the structural transitions necessary for viral uncoating (Yamayoshi et al., Nature 2009). Because of their high accessibility on the virion surface, the VP2 puff and VP3 knob are primary targets for neutralizing antibodies elicited by both natural infection and inactivated vaccines. Therapeutic development focuses on these regions to design monoclonal antibodies that can prevent viral entry or to monitor the efficacy of immunization programs against emerging viral variants (Shingler et al., J Virol 2013).

Other names
EV71 VP2 puffEV71 VP3 knobEnterovirus A71 capsid surface loopsVP2 EF loopVP3 BC loop
02

Mechanism of action

Induction of neutralizing antibodies that bind to surface-exposed loops to block viral attachment to host receptors or inhibit the conformational changes required for viral uncoating.

03

Biological functions

Viral attachmentViral entryCapsid assemblyHost cell receptor bindingViral uncoating
04

Disease associations

Hand, foot, and mouth diseaseEncephalitisAseptic meningitisAcute flaccid paralysisInfection
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral antigenic drift leading to immune escapeCross-reactivity with other Enterovirus A species
06

Interacting drugs

Inactivated Enterovirus 71 vaccine

2 more in the full profile.

07

Biomarkers

Anti-EV71 neutralizing antibody titerEV71 VP2-specific IgGEV71 VP3-specific IgG

Beyond the preview

Go deeper on Enterovirus 71 capsid protein VP2 and VP3 antigenic regions (EV71 VP2/VP3 epitopes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus 71 capsid protein VP2 and VP3 antigenic regions (EV71 VP2/VP3 epitopes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call